Strategy
Leader of the Pack
Indias pharmaceutical industry is without doubt one of the great success stories of recent years delivering economic benefits improvements in quality and significant growth Driven by the many producers both large and small in the bulk drug market this success has moved India towards a position of selfsufficiency in terms of national healthcare prov...
Under Development
Asia Still Evolving
The pharmaceutical market in the Asia Pacific region can be summed up in a single word evolving With the notable exception of Japan the markets in the region are still developing countries and are therefore undergoing significant change in just about every area affecting the pharmaceutical business Even the Japanese market the second largest in the...
Drug Development Challenges
The year marked a year low in the introduction of new medical treatments into the global market Over the last twoandahalf decades the pharmaceutical industry has been under increa
Indian Patent Law
Relevance to global pharmaceutical industry
In India the agreement on Trade Related Intellectual Property Rights TRIPS was brought about through an amendment to the Patent Act of and became active as on January and was obliged from that day to grant patents for pharmaceuticals In the Indian Patents Act which provides patent protection for pharmaceutical products or drugs
Sustainable Drug Discovery
Galapagos’ alliance strategy
In the past few years we have seen the announcement of many drug discovery alliances between biotechnology and major pharma companies Pharma companies have started to outsource increasing parts of their drug discovery RD to biotechs signalling a trend in a changing industry The alliances seek to capitalise on the synergies between biotechs innovati...
Getting from Challenge to Change
How far, how fast?
The biopharmaceutical industry is currently experiencing a very challenging environment There are many indicators lower number of product approvals consolidation among companies fewer Big Pharma companies among the top companies decrease in the relative profitability of drug manufacturers decline in the rate of increase of pharmaceutical sales the...
China seeking Protection
China is the worlds second largest pharmaceutical chemicals producer and is expected to triple its market share by Regulatory improvements are playing their part the State Food and Drug Administration SFDA was set up in June to take over the responsibilities of the former State Drug Administration for pharmaceutical manufacture and trade
Global Risk Management
Meeting the challenge
Risk management for prescription pharmaceuticals is both a high priority and a significant challenge for the biopharmaceutical industry today Numerous incidents involving the safety and risks of marketed pharmaceutical products in recent years have brought the issue to the forefront of public attention and regulatory scrutiny in the United States...
Eastern Promise
From small mature markets like Hong Kong to large booming markets such as India and China Asias pharmaceutical sector is expanding at a rapid rate Currently the total pharma market in Asia is estimated at around bn but this has more than doubled in the last ten years and many feel it will do so again in the next decade However the most significant...
Growth Spurt
When asked to explain why there should be a publication dedicated exclusively to the pharmaceutical market in Asia our first thought was of Elizabeth Barrett Brownings famous line of poetry let me count the ways The region could qualify for its own publication on any one of several counts size diversity complexity and potential But of course t
